Topics
View Supplement
Ninel Z. Gregori, MD; Allison J. Chen, MD, MPH; Omesh P. Gupta, MD, MBA; María H. Berrocal, MD; Jeremy D. Wolfe, MD, MS; Steve Charles, MD, FACS, FICS; and Adam Pflugrath, MD
Steve Charles, MD, FACS, FICS; Charles C. Wykoff, MD, PhD, FASRS, FACS; Audina M. Berrocal, MD; Sengul Ozdek, MD, FEBO; and Edward F. Hall, MD
Roselind Ni, BS; Turner D. Wibblesman, MD; Bita Momenaei, MD; Raziyeh Mahmoudzadeh, MD; and Jason Hsu, MD
January/February 2025 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent content supported by AbbVie, Johnson & Johnson Vision, Apellis, Regeneron, Dompe, Genentech, Bausch + Lomb, Alcon, Amgen, and Lumibird Medical
Editorially independent supported by Abbvie and Regenxbio
Sponsored by Genentech
Recent Supplements
Understanding Fast Progression in Geographic Atrophy
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
One to Watch: Samir N. Patel, MD
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE
_1773249222.png?auto=compress,format&w=75)
